Skip to main content
· 2/4/1993

Pfizer Inc. v. Elan Pharmaceutical Research Corp.

Citations

  • 812 F. Supp. 1352
  • 27 U.S.P.Q. 2d (BNA) 1161
  • 1993 U.S. Dist. LEXIS 1685
  • 1993 WL 32304

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • concluding that the court had discretion to disregard a foreign attorney’s affidavit on foreign law under Rule 44.1
  • finding that without a right to assign, the court “need look no further in determining that [the licensor] reserved substantial rights under the Agreement”
  • finding that without a right to assign, the court “need look no further in determining that [the licensor] reserved substantial rights under the Agreement”
  • “[notwithstanding” transferee’s failure to comply with conditions in agreement for suing in own name, agreement did not place transferee on equal footing with transferor regarding right to sue for infringement
  • “Nothing in Rule 44.1 requires a court to engage in private research; the rule preserves the court’s right to insist upon a complete presentation by counsel on the foreign-law issue.”
  • “Nothing in Rule 44.1 requires a court to engage in private before he, she, it can file a derivative suit on behalf of a corporation, that determination is not controlling here because in 1Globe 1

Source: CourtListener parenthetical corpus (CC0).

Judges: Longobardi

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.